We now expect to learn from studies of new transgenic mice over-expressing COUP-TFII combined or not with GLP-1 analog treatment whether COUP-TFII will reduce and/or reverse the development of diabetes. The gene discussed is GLP1R; the disease is diabetes mellitus.